Olivennes F, Lima-Ferreira A, Bergère M, Hazout A, Fanchin R, Selva J, Frydman R
Service de Gynécologie-Obstétrique, Hôpital Antoine Béclère, Clamart.
Presse Med. 1996 Nov 2;25(33):1599-603.
Management of male infertility has been totally changed with the development of intracytoplasmic sperm injection (ICSI). This technique, used for in vitro fertilization, consists in injecting a single spermatozoa into the ovum. Intracytoplasmic sperm injection can be proposed in case of severe male sterility (oligoasthenospermia) or after repeated failure of in vitro fertilization. Satisfactory rates of fecondation and pregnancy have been obtained. Results have also been obtained with sperm taken from the epididymis or testis. The risks involved concern the transmission of poorly understood genetic defects leading to the infertility. The rates of reported malformations and chromosome anomalies are quite low. Intracytoplasmic sperm injection can be useful in managing most cases of male infertility which to date have had to rely on donor sperm. Long-term results have not yet been obtained.
随着卵胞浆内单精子注射(ICSI)技术的发展,男性不育症的治疗方法发生了彻底改变。这项用于体外受精的技术是将单个精子注入卵子。在严重男性不育(少弱精子症)或体外受精反复失败的情况下,可以采用卵胞浆内单精子注射。已获得了令人满意的受精率和妊娠率。从附睾或睾丸获取的精子也取得了相应结果。所涉及的风险包括传递导致不育的尚不清楚的遗传缺陷。报道的畸形率和染色体异常率相当低。卵胞浆内单精子注射在治疗大多数男性不育病例中可能有用,而迄今为止这些病例不得不依赖供体精子。尚未获得长期结果。